drugset / Trial / NCT07386509
WU 345: Immune Responses to Adjuvanted and Non-adjuvanted Seasonal Influenza Vaccines in the Lymphoid Tissues.
Phase 0
Terminated
2 enrolled
Washington University School of Medicine
National Institute of Allergy and Infectious Diseases (NIAID) · collab
NaSingle-groupOpen-labelBasic science
Summary
Healthy adults (18-49 years of age) with no previous influenza virus vaccination history for at least three years prior to enrollment will be recruited to participate in this study. All subjects will concomitantly receive a single dose of both Fluad® and Afluria® administered intramuscularly in opposite deltoid muscles. Blood samples collected at 9 visits (screening, baseline, days 7, 14, 28, 60, 90, 120 and 180, fine needle aspiration (FNAs) from axillary lymph nodes from both axillae at baseline, days 7, 14, 28, 60, 90, 120 and 180.
Timeline
- Start
- 2020-03-17
- Primary completion
- 2022-11-04
- Completion
- 2022-11-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Afluria | Vaccine | — | Intramuscular |
| Subject | Fluad | Vaccine | — | Intramuscular |
Indications
No indication recorded.